respi 2 tranx

Upload: pinay-yaun

Post on 07-Apr-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/4/2019 respi 2 TRANX

    1/4

    1

    OPPORTUNISTIC MYCOSES

    Portal of entry: respiratory, mucocutaneous Infectious particles: conidia, mycelia Agents:

    o Widely distributed (as saprophytes,normal flora)

    o Invade only in the presence of someunderlying predispositions and mainly

    immunocompromised individuals

    I. Candidiasisa. Considered the most common

    systemic/ opportunistic fungal infection

    worldwide

    b. Mostly endogenous; occasionallyexogenously acquired (hospital setting)

    c. Clinical spectrum extremely diverse(from skin irritation to life-threatening

    infections)d. Leading fungal infection in patients with

    HIV-AIDS

    e. Occurs as:i. Cutaneous and subcutaneous

    (diseases of the skin and

    mucosal surfaces)

    ii. Systemic/ disseminated/invasive

    1. Candidemia (e.g.catheter related)

    2.

    Acute/ chronicdisseminate candidiasis

    3. Deep organ candidiasisf. Host factors predisposing to

    candidiasis:

    i. Physiological (pregnancy, age)ii. Trauma (burns, infection)

    iii. Hematological (neutropenia,cellular immunodeficiency)

    iv. Endocrinological (DM,hypothyroidism, Addisons

    disease)v. Iatrogenic (chemotherapeutics,

    corticosteroids, oral

    contraceptives, catheters, etc.)

    vi. Others (IV drug addiction,malnutrition)

    g. Caused by Candida spp.:i. C. albicans- most common

    agent, most pathogenic

    ii. Normal flora of skin, vagina,mucous membrane, stool, GIT(

    major colonizing habitat)

    iii. Ascomyceteiv. Dimorphic, reproduce by

    budding

    v. Infectious particles: yeast cells,pseudohyphae

    h. Laboratory Diagnosis:i. Gram Stain/ KOH/ histopath

    exam:

    - small budding yeast cells (4-5

    um) and psuedohyphae

    ii. Culture at room temp/ 37OC :-pseudohyphae with clusters of

    round blastoconidia

    -chlamydospores, yeast cellsand pseudohyphae on

    Chlamydospore/ Cornmeal Agar

    iii. Germ tube test (for C. albicans)iv. Others:

    1. Assimilation tests2. Biotyping3. Immunofluorescence4. Immunohistochemistry5. DNA probes, PCR6. Mannan antigen

    detection (RIA, ELISA,LAT)

    v. Treatment and prevention1. Cutaneous- topical

    nystatin, ketoconazole,

    fluconazole

    2. Systemic- ketoconazole,fluconazole,

    Subject: Microbiology and ParasitologyTopic:Lecturer: Dr. Eleanor P. PadlaDate of Lecture: Sept 1, 2011Transcriptionists:pinkyred :)Editor: pinkyredPages: 4

    SY

    2011-2012

  • 8/4/2019 respi 2 TRANX

    2/4

    2

    itraconazole,

    flucystosine, ampho B

    3. Avoid disturbing thenormal balance of

    microbial flora and

    intact host defense

    II. Aspergillosis

    a. Acquired following inhalation ofinfectious conidia

    b. Occurs as:i. Allergic form (allergic

    bronchopulmonary aspergillosis

    or ABPA)

    ii. Colonizing form/ pulmonary(aspergilloma)

    iii. Invasive/ disseminatediv. Mycotoxicosisv. Caused byAspergillus spp.:

    1. Most common cause-A. fumigates, A. flavus

    2. Ascomycetes3. Natural reservoir- soil,

    air

    4. Ubiquitous, frequentlaboratory

    contaminants

    vi. Laboratory Diagnosis:1. KOH/ HIstopath

    -wide, septate,

    dichotomously

    branching(45O) hyphae,

    conidial heads may be

    seen

    2. Culture:

    -conidiophore supports

    swollen vesicle covered

    with rows of phialides

    bearing radial chains of

    conidia3. ID of cultures

    -depends on difference

    of conidial heads

    4. Others:

    -serology

    -immunohistochemisrty

    - glactomannan antigen

    detection in serum

    vii. treatment and prevention

    - Allergic form- itraconazole,corticosteroids

    - Aspergilloma- surgery,Ampho B

    - Disseminated- itraconazole,fluconazole, ampho B

    - Avoid/ minimize exposureto conidia- Prophylactic low-dose

    Ampho B or itraconazole

    III. Cryptococcosis

    a. Aka Busse- Buschkes disease/Torulosis

    b. Believed to be acquired followinginhalation of non-encapsulated/

    minimally encapsulated yeast, or

    Basidiospores

    c. Primary site of infection: lungsd. One of the most common life-

    threatening infections in patients withAIDS

    e. Occurs as:i. Pulmonary (acute, chronic)

    ii. Disseminated1. Meningitis- most

    frequently diagnosed

    form

    iii. Neurotropism related tophenoloxidase activity

    iv. Cutaneous form: raref. Caused by basidiomycete yeasts:i. Cryptococcus neoformans

  • 8/4/2019 respi 2 TRANX

    3/4

    3

    ii. Cryptococcus gattiig. Encapsulated yeastsh. replicate by buddingi. Do not produce hyphae/ psuedohyphaej. Cryptococcus neoformans (Filobasidiella

    neoformans)i. common in temperate climate

    ii. affects immunocompromisedpatients

    iii. environmental reservoir:pigeon droppings

    iv. infectious particles:unencapsulated yeast,

    basidiospores

    v. includes serotypres A, D, ADhybrid

    1. C. neoformans var.neoformans (Serotype

    D)

    2. C. neoformans var.grubii(serotype A)

    vi. Clinical disease: meningitisk. C. gattii (Filobasidiella bacilliospora)

    i. In tropical/ subtropical climatesii. Effects immunocompetent

    individuals

    iii. Environmental reservoir:Eucalyptus trees

    iv. Infectious particles:basidiospores

    v. Includes: Serotypes B, Cvi. Clinical disease: pneumonia

    l. Virulence factors:i. Capsule

    1. Wide capsule2. Antiphagocytic3. 5 Serotypes: A,B,C,D,AD

    ii.

    Production of phenoloxidase1. Converts phenoliccompounds to melanin

    2. Survival mechanismwithin phagocytes

    m. Laboratory Diagnosisi. KOH/ India ink/ histopath

    1. Yeast cells with widecapsule

    ii. Culture (37oC)1. Creamy, mucoid yeast

    colonies

    2. Brown to black colonieson Niger/Bird Seed Agar

    iii. ID of cultures1. Biochemical tests (e.g.

    urease production)

    2. Caffeic acid test-phenoloxidase

    production

    3. Growth on L-canavarine-glycine-

    bromthymol blue (CBG)

    n. Treatmenti. Ampho B. ampho B-5 FC

    combination

    ii. Fluconazole prophylaxisfollowing primary treatment (in

    AIDS patients)

    IV. Zygomycosisa. Aka mucormycosis/phycomycosisb. Acquired following exposure to

    sporangiospores

    c. Risk factors: diabetic acidosis,immunosuppression

    d. Occurs as:i. Rhinocerebral (most frequent

    form)

    ii. Pulmonaryiii. Cutaneousiv. Gastrointestinalv. Disseminated- aggressively

    angio-incvasive, predominantly

    infarctive

    e. Caused by filamentous fungi (e.g.Rhizopus, Mucor, Absidia)

    i. Belong to order Mucorales,Class Zygomycetes

    ii. Natural reservoir: soil, air,water

    iii. Ubiquitous, frequentlyencountered as contaminantsf. Laboratory Diagnosis:

    i. KOH/Histopath1. Wide (ribbon-like),

    aseptate hyphae

    branching at right

    angles

    ii. Culture at RT

  • 8/4/2019 respi 2 TRANX

    4/4

    4

    1. Cotton-candyappearance of colonies

    2. Morphologic featuresidentify species

    3. Caution in interpretingresults

    g. Treatment and preventioni. Amphotericin Bii. Surgical debridement

    iii. Control of predisposing factors(e.g. Diabetes/ underlying

    disease

    V. Table 1. Characteristics of Species causingZygomycosis

    CHARACTER-

    ISTICS

    Rhizopus Mucor Absidia

    Sporangia Round Round PyriformSporangiosp

    ores

    Unbranched,

    nodal

    Branched,

    internodal

    Branched,

    internodal

    Columellae Hemi-

    spherical

    Round to

    oval

    Conical

    Rhizoids Well

    developed

    Absent Rudiment-

    ary

    Collarettes None

    remains

    when

    sporangial

    wall is

    dissolved

    Present

    when

    sporangial

    wall is

    dissolved

    Rhizopus

    Absidia

    _______END OF TRANX__________

    Hi to reych, arabels, anabels, eloh, jez, and to gempot!

    Happy birthday to Quen! And to Ramone, hehehehi

    din to Cuz! And to my dear roommate maanto

    Hannah, and rr! ^_^

    Happy studying!